AU2016348840B2 - Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) - Google Patents

Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) Download PDF

Info

Publication number
AU2016348840B2
AU2016348840B2 AU2016348840A AU2016348840A AU2016348840B2 AU 2016348840 B2 AU2016348840 B2 AU 2016348840B2 AU 2016348840 A AU2016348840 A AU 2016348840A AU 2016348840 A AU2016348840 A AU 2016348840A AU 2016348840 B2 AU2016348840 B2 AU 2016348840B2
Authority
AU
Australia
Prior art keywords
lactobacillus plantarum
composition
ecgc
cholesterol
ldl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016348840A
Other languages
English (en)
Other versions
AU2016348840A1 (en
Inventor
Stephen Patrick O'HARA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Probiotix Health Ltd
Original Assignee
Probiotix Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotix Health Ltd filed Critical Probiotix Health Ltd
Publication of AU2016348840A1 publication Critical patent/AU2016348840A1/en
Assigned to PROBIOTIX HEALTH LIMITED reassignment PROBIOTIX HEALTH LIMITED Request for Assignment Assignors: OPTIBIOTIX LIMITED
Application granted granted Critical
Publication of AU2016348840B2 publication Critical patent/AU2016348840B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
AU2016348840A 2015-11-02 2016-11-02 Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402) Active AU2016348840B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1519326.1 2015-11-02
GBGB1519326.1A GB201519326D0 (en) 2015-11-02 2015-11-02 Composition`
PCT/GB2016/053389 WO2017077285A1 (en) 2015-11-02 2016-11-02 Composition comprising lactobacillus plantarum 2830 (ecgc 13110402)

Publications (2)

Publication Number Publication Date
AU2016348840A1 AU2016348840A1 (en) 2018-04-26
AU2016348840B2 true AU2016348840B2 (en) 2023-07-20

Family

ID=55130539

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016348840A Active AU2016348840B2 (en) 2015-11-02 2016-11-02 Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402)

Country Status (7)

Country Link
US (1) US10898528B2 (enExample)
EP (1) EP3370746B1 (enExample)
JP (1) JP7073256B2 (enExample)
AU (1) AU2016348840B2 (enExample)
CA (1) CA3001472A1 (enExample)
GB (1) GB201519326D0 (enExample)
WO (1) WO2017077285A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319540D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201611782D0 (en) * 2016-07-06 2016-08-17 Optibiotix Ltd Composition
CN110760456B (zh) * 2019-07-09 2022-03-22 怀化学院 一种用于降解胆固醇的植物乳杆菌La1及其应用
CN116286534B (zh) * 2023-03-22 2023-11-17 东北农业大学 用于缓解高尿酸血症的植物乳植杆菌及其复合物和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067948A1 (en) * 2013-11-05 2015-05-14 Optibiotix Limited Composition
WO2015067947A1 (en) * 2013-11-05 2015-05-14 Optibiotix Limited Composition comprising lactobacillus plantarum
WO2015149818A1 (en) * 2014-04-03 2015-10-08 Oü Tervisliku Piima Biotehnoloogiate Arenduskeskus (Bio-Competence Centre Of Healthy Dairy Products) Lactobacillus plantarum inducia strain dsm 21379 as hypocholesterolemic agent and antimicrobial agent against clostridium difficile

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100436355B1 (ko) * 2001-08-14 2004-06-18 박정호 항산화물질, 옥타코사놀 및 베타글루칸을 함유한 발효음료및 그의 제조방법
CN102031229B (zh) * 2009-09-24 2012-05-30 家医国际生化股份有限公司 具有肠胃道吸附能力及排除胆固醇能力的植物乳杆菌
EP2311473A1 (en) * 2009-10-09 2011-04-20 AB-Biotics Producciones Industriales De Microbiotas, S.L. Lactobacillus plantarum strains as probiotics
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
CN105105145B (zh) * 2015-09-14 2022-04-22 吉林省命之元生物科技有限公司 一株植物乳杆菌及其在制备降血糖血脂的功能性食品中的应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067948A1 (en) * 2013-11-05 2015-05-14 Optibiotix Limited Composition
WO2015067947A1 (en) * 2013-11-05 2015-05-14 Optibiotix Limited Composition comprising lactobacillus plantarum
WO2015149818A1 (en) * 2014-04-03 2015-10-08 Oü Tervisliku Piima Biotehnoloogiate Arenduskeskus (Bio-Competence Centre Of Healthy Dairy Products) Lactobacillus plantarum inducia strain dsm 21379 as hypocholesterolemic agent and antimicrobial agent against clostridium difficile

Also Published As

Publication number Publication date
WO2017077285A1 (en) 2017-05-11
EP3370746B1 (en) 2021-03-10
AU2016348840A1 (en) 2018-04-26
JP2018531598A (ja) 2018-11-01
EP3370746A1 (en) 2018-09-12
CA3001472A1 (en) 2017-05-11
US20180318364A1 (en) 2018-11-08
JP7073256B2 (ja) 2022-05-23
GB201519326D0 (en) 2015-12-16
US10898528B2 (en) 2021-01-26

Similar Documents

Publication Publication Date Title
US11903979B2 (en) Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402)
US8349337B1 (en) Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
CA2326874C (en) Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
Kubota et al. Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract
US20250025522A1 (en) Composition
AU2016348840B2 (en) Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402)
KR100567717B1 (ko) 알파-글루코시다제 및 알파-아밀라제 억제제를 함유하는영양 보충제
AU2003236417B2 (en) Methods For Reducing Cholesterol Using Bacillus Coagulans Spores, Systems And Compositions
WO2021133950A1 (en) Polyphenol compositions and uses thereof
JP2012232918A (ja) 血糖値低下剤
NZ729232A (en) Dietetic composition with antidyslipidemic activity

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: PROBIOTIX HEALTH LIMITED

Free format text: FORMER APPLICANT(S): OPTIBIOTIX LIMITED

FGA Letters patent sealed or granted (standard patent)